Indegene
add_icon

Indegene

509.90
-10.30
(-1.98%)
Market Cap
12,253.77 Cr
PE Ratio
28.03
Volume
2,08,400.00
Day High - Low
519.95 - 505.80
52W High-Low
681.70 - 499.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
12,253.77 Cr
EPS
17.15
PE Ratio
28.03
PB Ratio
4.36
Book Value
119.25
EBITDA
641.50
Dividend Yield
0.38 %
Industry
Healthcare
Return on Equity
15.55
Debt to Equity
0.15
Analyst Rating and Forecast
- By Refinitiv from6 analysts
HOLD
Analysts have suggested that investors can hold this stock
Buy
Buy+33.33 %
+33.33 %
Hold
Hold+50.00 %
+50.00 %
Sell
Sell+16.67 %
+16.67 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Indegene Limited announced the amalgamation of two step-down subsidiaries, Indegene Aptilon Services Inc. and Trilogy Writing & Consulting Inc., to form Indegene Healthcare Canada Inc. effective January 01, 2026.
neutral
Indegene's Nomination and Remuneration Committee approved grants of 5,08,368 RSUs to eligible employees under the RSU 2020 Plan on December 31, 2025, with a four-year vesting schedule.
neutral
Indegene Limited's subsidiaries acquired 100% equity in Trilogy Writing & Consulting Inc. (Canada) for EUR 329,014 as part of internal restructuring completed on December 31, 2025.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
626.90
#1 25,260.27
54.47
#1 3,714.20
3.77
#1 496
-36.76
37.48
509.90
#2 12,253.77
#2 28.03
#2 2,946.50
#3 10.53
#2 407
#4 11.34
34.78
159.67
3,632.08
-17.61
17.60
-46.34
-161
-55.85
39.13
577.55
2,577.91
43.85
322.30
0.22
41
112.87
37.63
42.61
630.35
#1 13.56
10.20
#1 126.67
1
#1 493.75
77.88
71.20
167.66
-4.03
806.50
4.78
-56
22.07
32.03
69.75
110.45
-25.42
47.50
17.87
0
-100.00
63.80
16.00
26.30
33.09
84.00
5.00
2
-76.92
21.16
21.00
14.90
-1.12
2.10
-78.57
-13
-450.00
45.97
Growth Rate
Revenue Growth
10.53 %
Net Income Growth
20.79 %
Cash Flow Change
-12.96 %
ROE
-34.00 %
ROCE
-22.58 %
EBITDA Margin (Avg.)
-0.23 %

Quarterly Financial Results

Quarterly Financials
Jun 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
540
645
636
647
687
699
699
708
758
781
783
824
Expenses
413
535
511
515
525
534
548
561
589
608
606
664
EBITDA
127
111
125
133
162
164
151
148
170
173
177
160
Operating Profit %
21 %
15 %
16 %
19 %
22 %
21 %
19 %
18 %
18 %
20 %
20 %
17 %
Depreciation
10
20
20
20
18
19
20
19
20
21
22
23
Interest
2
12
13
12
12
12
12
4
3
3
4
4
Profit Before Tax
115
79
93
101
132
134
120
124
146
149
152
133
Tax
29
30
24
26
34
39
32
32
37
32
36
31
Net Profit
86
49
68
75
99
95
88
92
110
118
116
102
EPS in ₹
3.88
2.20
3.09
3.38
4.45
4.27
3.79
3.84
4.59
4.91
4.86
4.26

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
2025
Total Assets
329
600
596
1,354
2,204
2,546
3,326
Fixed Assets
104
119
86
138
664
646
678
Current Assets
185
418
459
1,130
1,449
1,791
2,530
Capital Work in Progress
0
0
0
0
0
0
4
Investments
0
13
0
120
614
797
1,290
Other Assets
225
468
510
1,096
926
1,103
1,355
Total Liabilities
329
600
596
1,354
2,204
2,546
3,326
Current Liabilities
158
247
199
440
489
611
565
Non Current Liabilities
18
369
64
149
651
506
146
Total Equity
152
-16
333
764
1,064
1,429
2,616
Reserve & Surplus
73
-105
324
764
1,020
1,385
2,567
Share Capital
79
0
0
0
44
44
48

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
25
143
-41
373
-433
115
52
Investing Activities
-18
-16
-81
-158
-896
-327
-677
Operating Activities
65
22
172
297
130
508
442
Financing Activities
-21
136
-132
234
333
-66
288

Share Holding

% Holding
Dec 2022
Mar 2024
Apr 2024
May 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
FIIs
0.00 %
3.56 %
0.00 %
0.00 %
3.79 %
4.82 %
5.03 %
5.24 %
10.05 %
11.30 %
DIIs
0.00 %
5.33 %
0.00 %
0.00 %
3.84 %
3.17 %
3.98 %
4.96 %
7.20 %
6.96 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
11.38 %
0.00 %
0.00 %
24.67 %
24.32 %
26.41 %
11.34 %
13.51 %
13.28 %
Others
100.00 %
79.73 %
100.00 %
100.00 %
67.70 %
67.69 %
64.58 %
78.45 %
69.24 %
68.46 %
No of Share Holders
44
4,43,785
82
82
2,03,599
1,51,440
1,53,789
1,44,708
1,51,997
1,51,809

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.39 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
17 Nov 2022 CHANGE OF NAME Change Of Name
NA
17 Nov 2022 0.00 0.00
06 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
06 Sept 2024 554.85 608.85
28 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Oct 2024 653.25 675.45
30 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Jan 2025 663.05 622.10
28 Apr 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Apr 2025 570.25 567.40
13 Jun 2025 DIVIDEND Dividend
2.00 /share
13 Jun 2025 567.40 598.55
26 Jun 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Jun 2025 609.15 580.55
31 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
31 Jul 2025 558.95 546.55
30 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Oct 2025 554.75 545.50

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20183 days ago
Announcement under Regulation 30 (LODR)-Restructuring10 days ago
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 31, 2025
Announcement under Regulation 30 (LODR)-AcquisitionDec 31, 2025
Closure of Trading WindowDec 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 23, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotDec 22, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSDec 19, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateDec 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 12, 2025
Announcement under Regulation 30 (LODR)-AcquisitionNov 10, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 03, 2025
Intimation Of Opening Of Trading WindowNov 01, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 31, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportOct 31, 2025
Disclosure Under SEBI (LODR) Regulations 2015 - Investment In Wholly Owned SubsidiaryOct 30, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationOct 30, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 30, 2025
Disclosure Under Regulation 30 Of SEBI(LODR) Regulations 2015 - Intimation Of GrantOct 30, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSOct 30, 2025
Outcome Of Board Meeting - Q2FY26 ResultsOct 30, 2025
Board Meeting Outcome for Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Outcome Of Board MeetingOct 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 23, 2025
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 23, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 17, 2025
Announcement under Regulation 30 (LODR)-AcquisitionOct 17, 2025
Reg. 34 (1) Annual Report.Oct 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 07, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationOct 02, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 01, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 01, 2025
Announcement under Regulation 30 (LODR)-AcquisitionOct 01, 2025
Closure of Trading WindowSep 26, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 24, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 19, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 01, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 21, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 19, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportAug 13, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotAug 13, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 06, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 02, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 01, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Sundaram Mid Cap Fund Direct-Growth
0.00%
-1276686
-0.51%
-0.48%
Sundaram Aggressive Hybrid Fund Direct-Growth
0.00%
-616846
-0.43%
-0.30%
Sundaram Business Cycle Fund Direct - Growth
0.00%
-431551
-1.26%
-1.26%
Sundaram Multi Asset Allocation Fund Direct - Growth
0.00%
-220240
-0.39%
-0.27%
Sundaram Flexi Cap Fund Direct - Growth
0.00%
-154761
-0.38%
0.00%
Helios Mid Cap Fund Direct-Growth
1.19%
147345
0.18%
0.11%
Sundaram Balanced Advantage Fund Direct-Growth
0.00%
-116648
-0.35%
-0.27%
Sundaram ELSS Tax Saver Fund Direct
0.00%
-108333
-0.41%
0.00%
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth
0.00%
-9522
-0.27%
-0.27%
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth
0.27%
1791
-0.01%
0.00%
HDFC BSE 500 Index Fund Direct - Growth
0.03%
1339
0.03%
0.03%
ICICI Prudential Nifty Smallcap 250 Index Fund Direct - Growth
0.27%
-690
-0.01%
0.00%
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth
0.27%
513
0.00%
0.00%
SBI Nifty Smallcap 250 Index Fund Direct - Growth
0.27%
-445
0.00%
0.00%
Motilal Oswal Nifty 500 Index Fund Direct - Growth
0.03%
359
0.00%
0.00%
Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth
0.27%
-271
-0.01%
0.00%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.00%
-235
-0.03%
-0.03%
HDFC Nifty500 Multicap 50:25:25 Index Fund Direct-Growth
0.07%
191
0.00%
0.00%
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
0.27%
-181
0.00%
0.00%
SBI Nifty 500 Index Fund Direct-Growth
0.03%
-109
0.00%
0.00%
Kotak Nifty Smallcap 250 Index Fund Direct-Growth
0.27%
91
0.00%
0.00%
ICICI Prudential Nifty 500 Index Fund Direct-Growth
0.03%
76
0.00%
0.00%
Nippon India Nifty 500 Equal Weight Index Fund Direct-Growth
0.20%
70
0.01%
0.01%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0.27%
-64
0.00%
0.00%
Axis Nifty 500 Index Fund Direct-Growth
0.03%
24
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
34.78
ATR(14)
Volatile
9.26
STOCH(9,6)
Neutral
33.63
STOCH RSI(14)
Oversold
4.10
MACD(12,26)
Bearish
-1.12
ADX(14)
Weak Trend
12.77
UO(9)
Bearish
35.43
ROC(12)
Downtrend And Accelerating
-4.18
WillR(14)
Oversold
-89.27

About Indegene

Indegene Limited is a global provider of digital-led commercialization services for the life sciences industry. The company offers solutions in analytics, technology, and commercial, medical, regulatory, and safety services to biopharmaceutical, emerging biotech, and medical devices companies. Indegene operates through four main segments: Enterprise Commercial Solutions, Omnichannel Activation, Enterprise Medical...more
Listing Date
13 May, 2024(1 Years, 30 days)
Chairperson NameManish Gupta